Tesla Inc. (NASDAQ:TSLA) shares rallied 5.6% this week after the electric vehicle maker unveiled plans for a massive $16.8 billion chip manufacturing facility, though the announcement has sparked intense debate among investors about how the ambitious project will be financed.
The stock closed Friday at $328.58, up 2.8% on the day and marking its strongest weekly performance since early July. The surge came as retail investors piled in, purchasing approximately $372 million worth of Tesla shares across five trading sessions—more than triple the previous week's inflow.
Terafab: A Giant Leap with Unanswered Questions
Tesla and SpaceX (NASDAQ:SPCX) jointly unveiled the Terafab project, a proposed manufacturing complex in Texas spanning 100 million square feet. The facility is designed to produce and package chips for Optimus robots, Cybercabs, and SpaceX data centers. CEO Elon Musk stated the initiative would enable AI chip production "at scale for use on Earth and in space," though no timeline for investment was specified.
The $16.8 billion initial outlay represents 38.6% of Tesla's cash and short-term investments as of June, and is 2.9 times the company's second-quarter capital expenditure. However, the companies have not disclosed how much each will contribute, leaving investors to speculate on the financial structure.
Financial Strain Already Evident
Tesla's second-quarter results, released earlier, revealed mounting pressure: revenue climbed 25.5% to $28.24 billion, driven by higher vehicle deliveries, but operating income plummeted 56.9% to $398 million. Research and development expenses surged 49.2% to $2.37 billion, illustrating the cost of aggressive expansion.
Free cash flow turned negative at -$1.1 billion, the first time in over two years, as capital expenditures reached $5.8 billion. The company's capital expenditure guidance for 2026 exceeds $25 billion, and the Terafab investment could push that figure higher.
Analyst Reactions Split
Jefferies Financial Group (NYSE:JEF) lowered its 2026 EBIT projection by 37% to $3.9 billion, maintaining a Hold rating with a $350 price target. UBS (NYSE:UBS) kept a Neutral stance with a $385 target, while Stifel Financial (NYSE:SF) reduced its price target from $508 to $491 but retained a Buy rating. The consensus among 47 analysts stands at Outperform with an average target of $396.62, implying a 20.7% upside from Friday's close.
Direxion analyst Ryan Lee described monetization as "the central concern" following the earnings miss, highlighting the uncertainty surrounding Tesla's AI-related spending.
Market Context and Catalysts
The broader market rallied on Friday after weaker-than-expected U.S. jobs data eased fears of imminent rate hikes. The Nasdaq Composite rose 1.3% for the day and gained 5.2% for the week, while the S&P 500 added 0.6% and advanced 3.6% weekly.
Tesla's China-made vehicle sales totaled 93,579 units in July, up 37.8% year-over-year and marking the ninth consecutive month of growth. In Europe, Dutch regulators approved Full Self-Driving, though specifics on safety evaluations were not disclosed; a broader EU ruling is expected in October.
Risks Ahead
Investors face several potential headwinds: further margin pressure from vehicle price cuts, the possibility of additional external funding for Terafab, regulatory delays affecting software revenue, and shifts in consumer demand or interest rates. The coming week brings consumer inflation data on Wednesday, producer prices on Thursday, and retail sales on Friday—metrics that could influence growth stocks like Tesla.
As one analyst noted, the critical question is not the scale of Terafab but who provides the funding, when capital outflows occur, and how quickly the investment generates returns.
